Pfizer - 53 Year Stock Price History | PFE

Historical daily share price chart and data for Pfizer since 1972 adjusted for splits and dividends. The latest closing stock price for Pfizer as of May 16, 2025 is 22.83.
  • The all-time high Pfizer stock closing price was 51.62 on December 16, 2021.
  • The Pfizer 52-week high stock price is 31.54, which is 38.2% above the current share price.
  • The Pfizer 52-week low stock price is 20.92, which is 8.4% below the current share price.
  • The average Pfizer stock price for the last 52 weeks is 26.99.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pfizer Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 24.5058 25.6872 26.4062 21.1858 22.8300 -10.86%
2024 26.2055 27.0458 29.8380 23.3251 25.6100 -2.22%
2023 32.7720 44.6079 44.6079 23.7708 26.1906 -41.26%
2022 42.7067 47.7478 47.7815 36.0233 44.5905 -10.41%
2021 34.9992 29.8573 51.6249 27.4599 49.7706 66.69%
2020 27.8481 28.9385 34.5212 21.2796 29.8573 3.07%
2019 29.0142 30.8326 32.2120 25.0734 28.9681 -6.91%
2018 27.4999 25.0817 32.9570 23.3620 31.1177 24.82%
2017 23.0516 21.8542 25.6048 20.6290 24.9302 15.90%
2016 21.3727 20.3878 24.2628 18.4078 21.5098 4.42%
2015 21.1883 19.3462 22.7057 19.2412 20.5984 7.09%
2014 18.4140 18.1695 19.8154 16.9577 19.2350 5.28%
2013 17.0393 14.9561 19.2074 14.9215 18.2709 26.21%
2012 13.1696 12.2049 14.8974 11.7592 14.4771 20.43%
2011 10.6408 9.4253 12.1272 9.1629 12.0216 28.78%
2010 8.7645 9.6840 10.2313 7.3788 9.3347 0.31%
2009 7.8985 8.8721 9.6430 5.7840 9.3054 8.20%
2008 9.0719 10.4384 10.9715 7.0171 8.6002 -16.96%
2007 11.2475 11.4433 12.3105 10.1605 10.3564 -8.14%
2006 10.9894 9.9740 12.2832 9.5800 11.2736 15.26%
2005 10.5530 10.7653 11.9325 8.6402 9.7810 -10.63%
2004 13.2663 14.1734 15.4891 9.8861 10.9443 -22.30%
2003 12.6093 12.3376 14.2904 11.2298 14.0857 17.75%
2002 13.5280 15.3861 16.2537 10.0618 11.9620 -22.16%
2001 15.9925 17.6047 17.6047 13.6476 15.3668 -12.47%
2000 15.7878 12.0600 18.6227 11.3794 17.5570 43.06%
1999 14.5192 15.4462 18.8093 11.9413 12.2728 -21.50%
1998 12.7263 9.3950 15.7745 9.1777 15.6338 68.92%
1997 6.9475 5.0186 9.6587 5.0186 9.2553 81.92%
1996 4.4591 3.7519 5.5474 3.6615 5.0876 33.99%
1995 2.8193 2.1768 3.9930 2.1374 3.7971 71.61%
1994 1.8438 1.8910 2.2520 1.5026 2.2126 15.31%
1993 1.7626 1.9602 2.0505 1.4723 1.9188 -2.28%
1992 2.0108 2.2304 2.2768 1.7747 1.9636 -11.96%
1991 1.5606 1.0401 2.2768 0.9688 2.2304 112.76%
1990 0.8745 0.8900 1.0580 0.7081 1.0483 20.33%
1989 0.7756 0.6986 0.9370 0.6613 0.8712 24.16%
1988 0.6389 0.5660 0.7122 0.5660 0.7017 29.30%
1987 0.7530 0.7015 0.8755 0.4845 0.5427 -21.37%
1986 0.6737 0.5498 0.8126 0.5168 0.6902 24.00%
1985 0.5015 0.4300 0.6130 0.4099 0.5566 23.69%
1984 0.3735 0.3703 0.4500 0.3135 0.4500 22.78%
1983 0.3899 0.3372 0.4523 0.3372 0.3665 6.91%
1982 0.2970 0.2533 0.3944 0.2445 0.3428 33.44%
1981 0.2336 0.2487 0.2578 0.1950 0.2569 3.30%
1980 0.1908 0.1692 0.2487 0.1487 0.2487 39.95%
1979 0.1477 0.1438 0.1839 0.1283 0.1777 23.57%
1978 0.1354 0.1145 0.1650 0.1077 0.1438 25.59%
1977 0.1095 0.1159 0.1166 0.0973 0.1145 -2.88%
1976 0.1119 0.1108 0.1249 0.1011 0.1179 8.36%
1975 0.1148 0.1221 0.1395 0.0929 0.1088 -12.26%
1974 0.1241 0.1603 0.1636 0.0815 0.1240 -22.65%
1973 0.1612 0.1591 0.1925 0.1432 0.1603 2.49%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $129.797B $63.627B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $717.806B 55.04
Johnson & Johnson (JNJ) United States $364.111B 15.06
AbbVie (ABBV) United States $325.053B 17.92
Roche Holding AG (RHHBY) Switzerland $248.931B 0.00
Novartis AG (NVS) Switzerland $231.500B 13.22
Merck (MRK) United States $190.989B 9.76
Sanofi (SNY) France $130.557B 12.48
Bayer (BAYRY) Germany $25.032B 5.10
Innoviva (INVA) United States $1.166B 12.22
Novo Nordisk (NVO) Denmark $0.000B 19.04